NCT07082829View on ClinicalTrials.gov

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

PHASE1RecruitingINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Excessive Daytime Sleepiness
Interventions
DRUG

ORX142 Tablets

ORX142 Tablets

OTHER

Placebo Tablets

Placebo Tablets

Trial Locations (1)

68502

RECRUITING

Site #1, Lincoln

Sponsors
All Listed Sponsors
lead

Centessa Pharmaceuticals (UK) Limited

INDUSTRY

NCT07082829 - A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age | Biotech Hunter | Biotech Hunter